Find information on Celiac Disease diagnosis, including clinical documentation, medical coding, and healthcare guidance. Learn about gluten-sensitive enteropathy, coeliac disease, and non-tropical sprue, focusing on symptoms, testing, and treatment options. This resource offers valuable insights for healthcare professionals and patients seeking information on Celiac Disease management and coding best practices.
Also known as
Celiac Disease
Celiac disease with intestinal malabsorption.
Tropical Sprue
Intestinal malabsorption due to tropical sprue.
Other Malabsorption
Malabsorption not otherwise specified.
Malabsorption Unspecified
Intestinal malabsorption, unspecified.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the diagnosis Celiac Disease?
When to use each related code
| Description |
|---|
| Autoimmune reaction to gluten. |
| Gluten sensitivity without the autoimmune component of Celiac Disease. |
| Allergic reaction to wheat protein, often rapid onset. |
Using only the unspecified celiac code (K90.0) without documenting the specific type (e.g., K90.81 for refractory celiac) leads to inaccurate severity reflection and reimbursement.
Coding celiac disease as confirmed when it's only suspected (R76.11) is improper until definitive diagnosis is made through biopsy, leading to denial of claims.
Failing to code related manifestations like dermatitis herpetiformis (L13.0) or anemia (D50-D64) with celiac can result in incomplete clinical picture and lower reimbursement.
Q: What are the most specific and sensitive serological tests for diagnosing celiac disease in adults presenting with atypical symptoms?
A: While tissue transglutaminase IgA (tTG-IgA) is often the first-line serological test for celiac disease, its sensitivity can be reduced in patients with IgA deficiency. For adults presenting with atypical symptoms like fatigue, iron-deficiency anemia, or osteoporosis, consider adding endomysial antibody (EMA) testing and total IgA levels. EMA has high specificity, and testing for IgA deficiency ensures accurate interpretation of tTG-IgA results. If IgA deficiency is present, IgG-based serological tests like tTG-IgG or deamidated gliadin peptide IgG (DGP-IgG) should be used. A combination of serological tests often provides the most comprehensive assessment, especially in complex presentations. Explore how different serological markers contribute to diagnostic accuracy in celiac disease.
Q: How can I differentiate between celiac disease, non-celiac gluten sensitivity (NCGS), and irritable bowel syndrome (IBS) in clinical practice when symptoms overlap?
A: Overlapping symptoms like abdominal pain, bloating, and altered bowel habits can make distinguishing between celiac disease, NCGS, and IBS challenging. Serological testing (tTG-IgA, EMA) and duodenal biopsy are crucial for confirming celiac disease. If serology is negative and celiac disease is ruled out, consider a trial of a gluten-free diet. Improvement in symptoms suggests NCGS, but it's important to note that this diagnosis is based on symptom response and lacks specific biomarkers. If symptoms persist despite a gluten-free diet, investigate for IBS using Rome IV criteria and consider further testing to exclude other gastrointestinal disorders. Learn more about the diagnostic criteria and management strategies for differentiating these overlapping conditions.
Patient presents with symptoms suggestive of celiac disease, including chronic diarrhea, abdominal pain, bloating, and weight loss. The patient reports experiencing these symptoms intermittently for the past six months, with exacerbations following the ingestion of gluten-containing foods such as bread, pasta, and beer. Family history is positive for autoimmune disorders, increasing the suspicion for celiac disease. Physical examination reveals abdominal distension and tenderness. Differential diagnosis includes irritable bowel syndrome, inflammatory bowel disease, and lactose intolerance. To confirm the diagnosis of celiac disease, serological testing for tissue transglutaminase IgA antibodies and endomysial antibodies will be performed. If serology is positive, an esophagogastroduodenoscopy with small bowel biopsy is indicated to assess for villous atrophy and confirm the diagnosis histologically. Depending on the diagnostic findings, the patient will be counseled on the importance of strict adherence to a gluten-free diet. Dietary management education, including guidance on gluten-free food choices and hidden sources of gluten, will be provided. Follow-up appointments will be scheduled to monitor symptom resolution, nutritional status, and adherence to the gluten-free diet. ICD-10 code K90.0 will be used for celiac disease. Long-term monitoring will be necessary to assess for complications of celiac disease such as anemia, osteoporosis, and small bowel lymphoma. Patient education materials on celiac disease, gluten-free diet resources, and support groups will be provided.